Assuming that VEGFR-1 is a “ligand trap” which binds excess VEGF-A in the blood of stroke patients, the reversed direction of changes in VEGFR-1 and VEGF-A levels can appear obvious [48,49]. The gene discussed is VEGFA; the disease is stroke disorder.